Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target Journal Article


Authors: Saborowski, A.; Saborowski, M.; Davare, M. A.; Druker, B. J.; Klimstra, D. S.; Lowe, S. W.
Article Title: Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
Abstract: Cholangiocarcinoma is the second most common primary liver cancer and responds poorly to existing therapies. Intrahepatic cholangiocarcinoma (ICC) likely originates from the biliary tree and develops within the hepatic parenchyma. We have generated a flexible orthotopic allograft mouse model of ICC that incorporates common genetic alterations identified in human ICC and histologically resembles the human disease. We examined the utility of this model to validate driver alterations in ICC and tested their suitability as therapeutic targets. Specifically, we showed that the fused-in-glioblastoma-c- ros-oncogene1 (FIG-ROS1(S); FIG- ROS) fusion gene dramatically accelerates ICC development and that its inactivation in established tumors has a potent antitumor effect. Our studies establish a versatile model of ICC that will be a useful preclinical tool and validate ROS1 fusions as potent oncoproteins and therapeutic targets in ICC and potentially other tumor types.
Keywords: controlled study; unclassified drug; oncoprotein; nonhuman; mouse; animal tissue; animal experiment; animal model; carcinogenesis; hybrid protein; gene inactivation; bile duct carcinoma; priority journal; article; fused in glioblastoma c ros oncogene 1
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 110
Issue: 48
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2013-11-26
Start Page: 19513
End Page: 19518
Language: English
DOI: 10.1073/pnas.1311707110
PROVIDER: scopus
PMCID: PMC3845141
PUBMED: 24154728
DOI/URL:
Notes: Cited By (since 1996):1 -- Export Date: 2 January 2014 -- CODEN: PNASA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David S Klimstra
    978 Klimstra
  2. Scott W Lowe
    249 Lowe